| | | | | | | |
 | JOHNSON & JOHNSON | -2.84% | 7.47% | 3.43% | 7.88% | 27.04% | 465 600 |
| ELI LILLY AND COMPANY | -2.95% | 12.50% | 14.99% | 39.17% | 186.69% | 285 909 |
| PFIZER, INC. | -2.35% | 11.50% | -14.21% | 29.50% | 16.94% | 284 248 |
 | ROCHE HOLDING AG | 0.36% | 5.38% | -15.93% | -8.63% | 14.19% | 270 886 |
| ABBVIE INC. | -0.42% | 6.29% | 12.62% | 34.95% | 109.69% | 269 467 |
 | NOVO NORDISK A/S | -1.41% | 1.67% | 3.82% | 46.24% | 124.21% | 248 487 |
| MERCK & CO., INC. | -2.67% | 4.38% | 19.90% | 19.56% | 9.59% | 232 372 |
 | ASTRAZENECA PLC | 1.19% | 6.50% | 25.77% | 25.82% | 68.71% | 203 700 |
| NOVARTIS AG | -0.26% | 2.92% | 0.81% | -4.30% | -10.35% | 184 125 |
| BRISTOL-MYERS SQUIBB COMPANY | -1.60% | 2.92% | 26.22% | 18.52% | 73.54% | 167 557 |
| AMGEN INC. | -0.55% | 2.14% | 8.24% | 0.28% | 32.14% | 130 083 |
| GSK PLC | 0.22% | 4.82% | 10.16% | 24.14% | 11.28% | 108 921 |
 | BAYER AG | -3.02% | -2.95% | 24.28% | 13.13% | -4.73% | 62 279 |
 | DAIICHI SANKYO CO., LTD. | -0.70% | 8.88% | 16.14% | 41.81% | 70.42% | 48 120 |
| CHUGAI PHARMACEUTICAL CO., LTD | -0.65% | 7.49% | -5.54% | -17.95% | 47.41% | 43 311 |
| | | | | | | |
| | Moyenne | -1.18% | 5.46% | 8.71% | 18.01% | 51.79% | |
| | Moyenne pondérée par Capi. | -1.39% | 6.20% | 6.83% | 19.52% | 57.32% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
